Tapewire

Nasdaq · USD

LGND

LIGAND PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
3825
SEC CIK
0000886163
Parsed reports
442

Last 12 months

Inside the activity.

0 purchase rows · 131 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202508
Dec 202508
Jan 202605
Feb 202605
Mar 2026032
Apr 2026011
May 2026014
Jun 2026016
Jul 202608
Aug 2026012
Sep 202606
Oct 202606

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 16, 2024 Filed Sep 18, 2024 23:55 UTC
Korenberg Matthew EPresident & COO
Exercise / conversionCommon Stock 671 $49.99 $33,543.29
Disclosure

SEC source: 0002001011-24-000082 · edgardoc.xml · nonDerivative · entry 5

Korenberg Matthew E · CIK 0001649903 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,987

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 16, 2024 Filed Sep 18, 2024 23:55 UTC
Korenberg Matthew EPresident & COO
Tax withholdingCommon Stock 472 $105.00 $49,560.00
Disclosure

SEC source: 0002001011-24-000082 · edgardoc.xml · nonDerivative · entry 4

Korenberg Matthew E · CIK 0001649903 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,316

Read SEC document
September 16, 2024 Filed Sep 18, 2024 23:55 UTC
Korenberg Matthew EPresident & COO
Exercise / conversionCommon Stock 849 $58.49 $49,658.01
Disclosure

SEC source: 0002001011-24-000082 · edgardoc.xml · nonDerivative · entry 3

Korenberg Matthew E · CIK 0001649903 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,788

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 16, 2024 Filed Sep 18, 2024 23:55 UTC
Korenberg Matthew EPresident & COO
Tax withholdingCommon Stock 485 $105.00 $50,925.00
Disclosure

SEC source: 0002001011-24-000082 · edgardoc.xml · nonDerivative · entry 2

Korenberg Matthew E · CIK 0001649903 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,939

Read SEC document
September 16, 2024 Filed Sep 18, 2024 23:55 UTC
Korenberg Matthew EPresident & COO
Exercise / conversionCommon Stock 914 $55.75 $50,955.50
Disclosure

SEC source: 0002001011-24-000082 · edgardoc.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,424

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 28, 2024 Filed Aug 31, 2024 00:56 UTC
Reardon AndrewCLO & Secretary
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 1,500 $0.00 Strike: $52.27 $0.00
Disclosure

SEC source: 0002001011-24-000079 · edgardoc.xml · derivative · entry 3

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,444

Underlying: Common Stock · 1,500 shares

Expires 2032-08-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vests and is exercisable as to 12.5% of the underlying shares on February 1, 2023, and in 42 substantially equal monthly installments thereafter.

Read SEC document
August 28, 2024 Filed Aug 31, 2024 00:56 UTC
Reardon AndrewCLO & Secretary
SaleCommon Stock 1,500 $106.39 $159,590.55
Disclosure

SEC source: 0002001011-24-000079 · edgardoc.xml · nonDerivative · entry 2

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,534

F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $106.3200 to $106.4700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 28, 2024 Filed Aug 31, 2024 00:56 UTC
Reardon AndrewCLO & Secretary
Exercise / conversionCommon Stock 1,500 $52.27 $78,405.00
Disclosure

SEC source: 0002001011-24-000079 · edgardoc.xml · nonDerivative · entry 1

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,034

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 28, 2024 Filed Aug 31, 2024 01:00 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionIncentive Stock Option (right to buy) · Derivative 546 $0.00 Strike: $70.04 $0.00
Disclosure

SEC source: 0002001011-24-000080 · edgardoc.xml · derivative · entry 4

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 546 shares

Expires 2029-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: As per the separation of OmniAb Inc. from the issuer, 402 stock options were vested and exercisable as of November 1, 2022, whereas 144 options vest in 3 substantially equal monthly installments beginning on December 1, 2022.

Read SEC document
August 28, 2024 Filed Aug 31, 2024 01:00 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 207 $0.00 Strike: $57.22 $0.00
Disclosure

SEC source: 0002001011-24-000080 · edgardoc.xml · derivative · entry 3

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,309

Underlying: Common Stock · 207 shares

Expires 2030-10-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock option vests and is exercisable as to approximately 14% of the underlying shares on April 1, 2021, approximately 73% of the underlying shares in 32 substantially equal monthly installments on May 5, 2021, and approximately 13% of the underlying shares in 10 substantially equal monthly installments thereafter.

Read SEC document
August 28, 2024 Filed Aug 31, 2024 01:00 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionCommon Stock 546 $70.04 $38,241.84
Disclosure

SEC source: 0002001011-24-000080 · edgardoc.xml · nonDerivative · entry 2

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,399

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 28, 2024 Filed Aug 31, 2024 01:00 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionCommon Stock 207 $57.22 $11,844.54
Disclosure

SEC source: 0002001011-24-000080 · edgardoc.xml · nonDerivative · entry 1

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,853

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 26, 2024 Filed Aug 27, 2024 00:15 UTC
Korenberg Matthew EPresident & COO
SaleCommon Stock 5,212 $106.32 $554,147.14
Disclosure

SEC source: 0002001011-24-000078 · edgardoc.xml · nonDerivative · entry 5

Korenberg Matthew E · CIK 0001649903 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,510

F5 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $105.8100 to $106.6900. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 26, 2024 Filed Aug 27, 2024 00:15 UTC
Korenberg Matthew EPresident & COO
SaleCommon Stock 6,177 $105.02 $648,683.83
Disclosure

SEC source: 0002001011-24-000078 · edgardoc.xml · nonDerivative · entry 4

Korenberg Matthew E · CIK 0001649903 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,722

F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $104.7200 to $105.6700. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 23, 2024 Filed Aug 27, 2024 00:15 UTC
Korenberg Matthew EPresident & COO
SaleCommon Stock 4,275 $105.13 $449,438.87
Disclosure

SEC source: 0002001011-24-000078 · edgardoc.xml · nonDerivative · entry 3

Korenberg Matthew E · CIK 0001649903 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,899

F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $105.0000 to $105.4450. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 23, 2024 Filed Aug 27, 2024 00:15 UTC
Korenberg Matthew EPresident & COO
SaleCommon Stock 2,037 $104.09 $212,040.50
Disclosure

SEC source: 0002001011-24-000078 · edgardoc.xml · nonDerivative · entry 2

Korenberg Matthew E · CIK 0001649903 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,174

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $104.0000 to $104.3800. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 22, 2024 Filed Aug 27, 2024 00:15 UTC
Korenberg Matthew EPresident & COO
SaleCommon Stock 1,157 $105.54 $122,109.78
Disclosure

SEC source: 0002001011-24-000078 · edgardoc.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,211

F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $105.2500 to $105.6500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 10, 2024 Filed Jun 3, 2025 00:06 UTC
Reardon AndrewCLO & Secretary
Tax withholdingCommon Stock 897 $100.16 $89,839.04
Disclosure

SEC source: 0002001011-25-000037 · edgardoc.xml · nonDerivative · entry 1

Reardon Andrew · CIK 0001950232 · CLO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,637

F1 · kind: Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.

Read SEC document
August 09, 2024 Filed Aug 13, 2024 21:21 UTC
Korenberg Matthew EPresident & COO
SaleCommon Stock 18,245 $98.50 $1,797,132.50
Disclosure

SEC source: 0002001011-24-000071 · edgardoc.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,368

Read SEC document
August 08, 2024 Filed Aug 9, 2024 21:52 UTC
Davis Todd CDirector · Chief Executive Officer
PurchaseCommon Stock 2,500 $97.39 $243,480.50
Disclosure

SEC source: 0002001011-24-000067 · edgardoc.xml · nonDerivative · entry 1

Davis Todd C · CIK 0001392029 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,010

Read SEC document
June 28, 2024 Filed Jul 2, 2024 23:45 UTC
Reardon AndrewChief Legal Officer &
OtherCommon Stock 329 $60.71 $19,972.60
Disclosure

SEC source: 0002001011-24-000065 · edgardoc.xml · nonDerivative · entry 1

Reardon Andrew · CIK 0001950232 · Chief Legal Officer &

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,534

F1 · kind: These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 28, 2024 Filed Jul 2, 2024 23:45 UTC
Korenberg Matthew EPresident & Chief Operating
OtherCommon Stock 350 $60.71 $21,247.45
Disclosure

SEC source: 0002001011-24-000064 · edgardoc.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · President & Chief Operating

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,613

F1 · kind: These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 28, 2024 Filed Jul 2, 2024 23:45 UTC
Espinoza OctavioChief Financial Officer
OtherCommon Stock 267 $60.71 $16,208.77
Disclosure

SEC source: 0002001011-24-000063 · edgardoc.xml · nonDerivative · entry 1

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,646

F1 · kind: These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 28, 2024 Filed Jul 2, 2024 23:44 UTC
Davis Todd CDirector · Chief Executive Officer
OtherCommon Stock 350 $60.71 $21,247.45
Disclosure

SEC source: 0002001011-24-000062 · edgardoc.xml · nonDerivative · entry 1

Davis Todd C · CIK 0001392029 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,510

F1 · kind: These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
June 14, 2024 Filed Jun 19, 2024 01:27 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 5,444 $0.00 Strike: $80.06 $0.00
Disclosure

SEC source: 0002001011-24-000060 · edgardoc.xml · derivative · entry 2

Zimmermann Martine · CIK 0001994049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,444

Underlying: Common Stock · 5,444 shares

Expires 2034-06-14

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 14, 2024 Filed Jun 19, 2024 01:27 UTC GrantCommon Stock 1,252 $0.00 $0.00
Disclosure

SEC source: 0002001011-24-000060 · edgardoc.xml · nonDerivative · entry 1

Zimmermann Martine · CIK 0001994049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,537

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 14, 2024 Filed Jun 19, 2024 01:27 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 5,444 $0.00 Strike: $80.06 $0.00
Disclosure

SEC source: 0002001011-24-000059 · edgardoc.xml · derivative · entry 2

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,444

Underlying: Common Stock · 5,444 shares

Expires 2034-06-14

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 14, 2024 Filed Jun 19, 2024 01:27 UTC GrantCommon Stock 1,252 $0.00 $0.00
Disclosure

SEC source: 0002001011-24-000059 · edgardoc.xml · nonDerivative · entry 1

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,515

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 14, 2024 Filed Jun 19, 2024 01:26 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 5,444 $0.00 Strike: $80.06 $0.00
Disclosure

SEC source: 0002001011-24-000058 · edgardoc.xml · derivative · entry 2

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,444

Underlying: Common Stock · 5,444 shares

Expires 2034-06-14

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 14, 2024 Filed Jun 19, 2024 01:26 UTC GrantCommon Stock 1,252 $0.00 $0.00
Disclosure

SEC source: 0002001011-24-000058 · edgardoc.xml · nonDerivative · entry 1

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,775

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 14, 2024 Filed Jun 19, 2024 01:26 UTC
Haas JasonDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 5,444 $0.00 Strike: $80.06 $0.00
Disclosure

SEC source: 0002001011-24-000057 · edgardoc.xml · derivative · entry 2

Haas Jason · CIK 0001883821 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,444

Underlying: Common Stock · 5,444 shares

Expires 2034-06-14

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 14, 2024 Filed Jun 19, 2024 01:26 UTC
Haas JasonDirector
GrantCommon Stock 1,252 $0.00 $0.00
Disclosure

SEC source: 0002001011-24-000057 · edgardoc.xml · nonDerivative · entry 1

Haas Jason · CIK 0001883821 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,397

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 14, 2024 Filed Jun 19, 2024 01:26 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 5,444 $0.00 Strike: $80.06 $0.00
Disclosure

SEC source: 0002001011-24-000056 · edgardoc.xml · derivative · entry 2

Gray Nancy Ryan · CIK 0001714949 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,444

Underlying: Common Stock · 5,444 shares

Expires 2034-06-14

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 14, 2024 Filed Jun 19, 2024 01:26 UTC GrantCommon Stock 1,252 $0.00 $0.00
Disclosure

SEC source: 0002001011-24-000056 · edgardoc.xml · nonDerivative · entry 1

Gray Nancy Ryan · CIK 0001714949 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,885

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 14, 2024 Filed Jun 19, 2024 01:25 UTC
Aryeh JasonDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 5,444 $0.00 Strike: $80.06 $0.00
Disclosure

SEC source: 0002001011-24-000055 · edgardoc.xml · derivative · entry 4

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,444

Underlying: Common Stock · 5,444 shares

Expires 2034-06-14

F3 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 14, 2024 Filed Jun 19, 2024 01:25 UTC
Aryeh JasonDirector
GrantCommon Stock 1,252 $0.00 $0.00
Disclosure

SEC source: 0002001011-24-000055 · edgardoc.xml · nonDerivative · entry 1

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,080

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 14, 2024 Filed Jun 25, 2024 23:45 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 5,444 $0.00 Strike: $80.06 $0.00
Disclosure

SEC source: 0002001011-24-000061 · edgardoc.xml · derivative · entry 2

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,444

Underlying: Common Stock · 5,444 shares

Expires 2034-06-14

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
June 14, 2024 Filed Jun 25, 2024 23:45 UTC GrantCommon Stock 1,252 $0.00 $0.00
Disclosure

SEC source: 0002001011-24-000061 · edgardoc.xml · nonDerivative · entry 1

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,178

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 14, 2024. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Read SEC document
May 17, 2024 Filed May 17, 2024 23:59 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 5,022 $0.00 Strike: $52.84 $0.00
Disclosure

SEC source: 0002001011-24-000053 · edgardoc.xml · derivative · entry 12

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,179

Underlying: Common Stock · 5,022 shares

Expires 2032-05-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The stock option vests and is exercisable as to approximately 14% of the underlying shares on August 5, 2022, approximately 64% of the underlying shares in 28 substantially equal monthly installments beginning on September 5, 2022, and approximately 22% of the underlying shares in 12 substantially equal monthly installments thereafter.

Read SEC document
May 17, 2024 Filed May 17, 2024 23:59 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionIncentive Stock Option (right to buy) · Derivative 145 $0.00 Strike: $68.74 $0.00
Disclosure

SEC source: 0002001011-24-000053 · edgardoc.xml · derivative · entry 11

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 145 shares

Expires 2029-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The stock option vests as to 50% of the underlying shares on January 11, 2023 and as to the remaining on February 11, 2023.

Read SEC document
May 17, 2024 Filed May 17, 2024 23:59 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,544 $0.00 Strike: $63.62 $0.00
Disclosure

SEC source: 0002001011-24-000053 · edgardoc.xml · derivative · entry 10

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,456

Underlying: Common Stock · 1,544 shares

Expires 2032-12-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Grant to reporting person of stock options that will vest and become exercisable over a 4-year period measured from December 5, 2022, with 12-1/2% of the shares subject to the stock options vesting on the date that is six months after December 5, 2022 and the remaining stock options vesting in 42 equal monthly installments thereafter.

Read SEC document
May 17, 2024 Filed May 17, 2024 23:59 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 206 $0.00 Strike: $57.22 $0.00
Disclosure

SEC source: 0002001011-24-000053 · edgardoc.xml · derivative · entry 9

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,516

Underlying: Common Stock · 206 shares

Expires 2030-10-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: As per the separation of OmniAb Inc. from the issuer, 4,096 stock options were vested and exercisable as of November 1, 2022, whereas 3,766 options vest in 23 substantially equal monthly installments beginning on December 1, 2022.

Read SEC document
May 17, 2024 Filed May 17, 2024 23:59 UTC
Espinoza OctavioChief Financial Officer
SaleCommon Stock 134 $86.65 $11,611.06
Disclosure

SEC source: 0002001011-24-000053 · edgardoc.xml · nonDerivative · entry 8

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,379

Read SEC document
May 17, 2024 Filed May 17, 2024 23:59 UTC
Espinoza OctavioChief Financial Officer
SaleCommon Stock 5,022 $86.67 $435,232.63
Disclosure

SEC source: 0002001011-24-000053 · edgardoc.xml · nonDerivative · entry 7

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,513

F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $86.0300 to $86.8200. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 17, 2024 Filed May 17, 2024 23:59 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionCommon Stock 5,022 $52.84 $265,362.48
Disclosure

SEC source: 0002001011-24-000053 · edgardoc.xml · nonDerivative · entry 6

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,535

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 17, 2024 Filed May 17, 2024 23:59 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionCommon Stock 145 $68.74 $9,967.30
Disclosure

SEC source: 0002001011-24-000053 · edgardoc.xml · nonDerivative · entry 5

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,513

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 17, 2024 Filed May 17, 2024 23:59 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionCommon Stock 1,544 $63.62 $98,229.28
Disclosure

SEC source: 0002001011-24-000053 · edgardoc.xml · nonDerivative · entry 4

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,368

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 17, 2024 Filed May 17, 2024 23:59 UTC
Espinoza OctavioChief Financial Officer
Exercise / conversionCommon Stock 206 $57.22 $11,787.32
Disclosure

SEC source: 0002001011-24-000053 · edgardoc.xml · nonDerivative · entry 3

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,824

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 16, 2024 Filed May 17, 2024 23:59 UTC
Espinoza OctavioChief Financial Officer
SaleCommon Stock 2,264 $86.00 $194,711.70
Disclosure

SEC source: 0002001011-24-000053 · edgardoc.xml · nonDerivative · entry 2

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,618

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $86.0000 to $86.0350. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 15, 2024 Filed May 17, 2024 23:59 UTC
Espinoza OctavioChief Financial Officer
SaleCommon Stock 5,873 $86.01 $505,148.48
Disclosure

SEC source: 0002001011-24-000053 · edgardoc.xml · nonDerivative · entry 1

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,882

F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $86.0000 to $86.1500. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.